Your browser doesn't support javascript.
loading
Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels / Journal of the Korean Cancer Association, 대한암학회지
Article de En | WPRIM | ID: wpr-889757
Bibliothèque responsable: WPRO
ABSTRACT
Purpose@#We aimed to investigate the prognostic value of serum β2-microglobulin for patients with Burkitt lymphoma (BL) and to propose a risk-stratifying classification system. @*Materials and Methods@#A prospective registry-based cohort study of BL patients treated with dose-intensive or effective dose-adjusted chemotherapies (n=81) was conducted. Survival outcomes were compared based on previously reported risk groups and/or serum β2-microglobulin levels. A risk-stratifying classification system incorporating serum β2-microglobulin levels was proposed and validated in an independent validation cohort (n=60). @*Results@#The median age was 47 years, and 57 patients (70.4%) were male. Patients with high serum β2-microglobulin levels (> 2 mg/L) had significantly worse progression-free survival (PFS) and overall survival (OS) (p 2 mg/L) was independently associated with a shorter PFS (hazards ratio [HR], 3.56; p=0.047) and OS (HR, 4.66; p=0.043). The new classification system incorporating the serum β2-microglobulin level allowed the stratification of patients into three distinct risk subgroups with 5-year OS rates of 100%, 89.5%, and 62.5%. In an independent cohort of BL, the system was validated by stratifying patients with different survival outcomes. @*Conclusion@#Serum β2-microglobulin level is an independent prognostic factor for BL patients. The proposed β2-microglobulin–based classification system could stratify patients with distinct survival outcomes, which may help define appropriate treatment approaches for individual patients.
Texte intégral: 1 Indice: WPRIM Type d'étude: Observational_studies / Prognostic_studies langue: En Texte intégral: Cancer Research and Treatment Année: 2021 Type: Article
Texte intégral: 1 Indice: WPRIM Type d'étude: Observational_studies / Prognostic_studies langue: En Texte intégral: Cancer Research and Treatment Année: 2021 Type: Article